We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
EP34623
Abstract: . In the process of VLP based vaccines design, development, and manufacturing, working with partners who understand the challenges can dramatically improve efficiency.Summary: Virus-like Particles (VLPs) Based Vaccine, an approach that fights viruses with its own weapon, is one of the most exciting emerging vaccine technologies for generating effective and long-lasting protection. References: https://www.creative-biolabs.com/resource/vaccine/pdf/com/flyer/Virus-Like-Particles-Based-Vaccine-Development-Services.pdf
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Related Posters
Active lifestyle and cognitive performance in older adults
Hana Georgi, Zuzana Frydrychová
Improving the Chemical Synthesis and Performance of Extended-Length Guide RNAs for Genome Editing and Control of Gene Expression
Laurakay Bruhn, Bo Curry, Rob Kaiser, Ben Lunstad, Ryan McCaffrey, Joel Myerson, Subhadeep Roy, Daniel Ryan, Israel Steinfeld, David Taussig, Justin Townsend, Suhani Thakker, Doug Dellinger
Modulating the Activity of CRISPR-Cas with Chemical Modifications in Single-Guide RNAs
Daniel Ryan, David Taussig, Suhani Thakker, Israel Steinfeld, Ben Lunstad, Rob Kaiser, Ryan McCaffrey, Justin Townsend, Patrick Chaffey, Bo Curry, Doug Dellinger, Laurakay Bruhn
Probiocs Related Products at Creative Enzymes
Creative Enzymes
Antigen Products for Vaccine Development
Creative Biolabs